Financhill
Back

CytoMed Therapeutics Ltd. 10K Form

Sell
29

GDTC
CytoMed Therapeutics Ltd.

Last Price:
$1.88
Seasonality Move:
-6.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDTC News And Ratings

See the #1 stock for the next 7 days that we like better than GDTC

GDTC Financial Statistics

Sales & Book Value

Annual Sales: $52K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.65
Price / Book: 3.1

Profitability

EPS (TTM): -0.19340
Net Income (TTM): $-2.3M
Gross Margin: $-515.8K
Return on Equity: 0%
Return on Assets: 0%

CytoMed Therapeutics Ltd. Earnings Forecast

Key CytoMed Therapeutics Ltd. Financial Ratios

  • The Gross Profit Margin over the past 5 years for GDTC is -991.92%.
  • The Selling, General & Administrative Expenses for GDTC have been equal to 690.38% of Gross Profit Margin.
  • The Research & Development expenses have been 2,747.69% of Revenue.
  • The Net Earning history of GDTC is -3,628.85% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

CytoMed Therapeutics Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GDTC
Website: cytomed.sg

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GDTC Technical Analysis vs Fundamental Analysis

Sell
29
CytoMed Therapeutics Ltd. (GDTC) is a Sell

Is CytoMed Therapeutics Ltd. a Buy or a Sell?